# Michel Michaelides

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michel-michaelides/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,860 |
| Field | Retinal Development and Disorders |
| h-index | 79 |
| i10-index | 373 |
| Last Known Institution | Moorfields Eye Hospital NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5077508604 |
| ORCID iD | 0000-0002-1552-7046 |
| Works | 813 |

## Researcher papers

- [Long-Term Effect of Gene Therapy on Leber’s Congenital Amaurosis](https://scholariq.org/papers/long-term-effect-of-gene-therapy-on-leber-s-congenital-amaurosis/)
- [A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010](https://scholariq.org/papers/a-comparison-of-the-causes-of-blindness-certifications-in-england-and-wales-in/)
- [Whole-genome sequencing of patients with rare diseases in a national health system](https://scholariq.org/papers/whole-genome-sequencing-of-patients-with-rare-diseases-in-a-national-health/)
- [A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)](https://scholariq.org/papers/a-prospective-randomized-trial-of-intravitreal-bevacizumab-or-laser-therapy-in/)
- [Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease](https://scholariq.org/papers/comprehensive-rare-variant-analysis-via-whole-genome-sequencing-to-determine-the/)
- [A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema](https://scholariq.org/papers/a-2-year-prospective-randomized-controlled-trial-of-intravitreal-bevacizumab-or/)
- [Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options](https://scholariq.org/papers/stargardt-disease-clinical-features-molecular-genetics-animal-models-and/)
- [Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions](https://scholariq.org/papers/leber-congenital-amaurosis-early-onset-severe-retinal-dystrophy-clinical/)
- [100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.](https://scholariq.org/papers/100-000-genomes-pilot-on-rare-disease-diagnosis-in-health-care-preliminary/)
- [The cone dysfunction syndromes: Table 1](https://scholariq.org/papers/the-cone-dysfunction-syndromes-table-1/)
- [Skills Acquisition and Assessment after a Microsurgical Skills Course for Ophthalmology Residents](https://scholariq.org/papers/skills-acquisition-and-assessment-after-a-microsurgical-skills-course-for/)

## Researcher topics

- [Retinal Development and Disorders](https://scholariq.org/topics/retinal-development-and-disorders/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Ophthalmology and Visual Impairment Studies](https://scholariq.org/topics/ophthalmology-and-visual-impairment-studies/)
- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)
- [Connexins and lens biology](https://scholariq.org/topics/connexins-and-lens-biology/)

## Researcher university

- [Moorfields Eye Hospital NHS Foundation Trust](https://scholariq.org/institutions/moorfields-eye-hospital-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.